S$4.09 0.0 0.3%
Last Trade - 3:59am
| Market Cap | £1.37bn |
| Enterprise Value | £1.78bn |
| Revenue | £65.5m |
| Position in Universe | 630th / 6015 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.4 | 102.7 | 110.1 | 109.9 | 112.8 | 115.2 | 116.8 | 117.2 | +2.8% | ||
| +23.2 | -44.7 | +37.2 | +10.4 | +49.7 | -18.8 | -33.8 | +1.48 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Parkway Life Real Estate Investment Trust (PLife REIT) is a Singapore-based healthcare REIT. PLife REIT invests in real estate and real estate-related assets that are used primarily for healthcare and healthcare-related purposes, including hospitals, healthcare facilities, and real estate and real estate assets used for healthcare research, education, and the manufacturing or storage of drugs, medicine, and other healthcare goods and devices. Its operating segments include Hospitals and medical centers, Nursing homes, and Pharmaceutical Manufacturing and Distribution Facility. It owns a portfolio of private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has over 49 assets located in Japan, including one pharmaceutical product distributing and manufacturing facility in Chiba Prefecture as well as over 48 nursing home and care facility properties. Parkway Trust Management Limited is the manager of the Trust.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| Incorporated | July 12, 2007 |
| Public Since | August 23, 2007 |
| No. of Shareholders: | 8,755 |
| No. of Employees: | n/a |
| Sector | Financials |
| Industry | Residential & Commercial REITs |
| Index | |
| Exchange | Singapore Exchange Securities Trading Ltd |
| Shares in Issue | 605,002,386 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 80 Robinson Road #02-00, 068898, Singapore |
| Web | http://www.plifereit.com/ |
| Phone | +65 6 2364333 |
| Contact | () |
| Auditors | KPMG LLP |
As of 3:59am, shares in Parkway Life Real Estate Investment Trust are trading at S$4.09, giving the company a market capitalisation of £1.37bn. This share price information is delayed by 15 minutes.
Shares in Parkway Life Real Estate Investment Trust are currently trading at S$4.09 and the price has moved by 20.71% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Parkway Life Real Estate Investment Trust price has moved by 3.98% over the past year.
Of the analysts with advisory recommendations for Parkway Life Real Estate Investment Trust, there are there are currently 1 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Parkway Life Real Estate Investment Trust is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Parkway Life Real Estate Investment Trust is scheduled to issue upcoming financial results on the following dates:
The Parkway Life Real Estate Investment Trust dividend yield is 2.93% based on the trailing twelve month period.
Last year, Parkway Life Real Estate Investment Trust paid a total dividend of 0.12, and it currently has a trailing dividend yield of 2.93%. Looking ahead, Parkway Life Real Estate Investment Trust has not announced an ex-dividend date yet.
Parkway Life Real Estate Investment Trust has yet to annouce their ex-dividend date. The historic dividend yield on Parkway Life Real Estate Investment Trust shares is currently 2.93%.
To buy shares in Parkway Life Real Estate Investment Trust you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Parkway Life Real Estate Investment Trust are currently trading at S$4.09, giving the company a market capitalisation of £1.37bn.
Here are the trading details for Parkway Life Real Estate Investment Trust:
Based on an overall assessment of its quality, value and momentum, Parkway Life Real Estate Investment Trust is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Parkway Life Real Estate Investment Trust are currently priced at S$4.09. At that level they are trading at 24.26% premium to the analyst consensus target price of 0.00.
Analysts covering Parkway Life Real Estate Investment Trust currently have a consensus Earnings Per Share (EPS) forecast of 0.135 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Parkway Life Real Estate Investment Trust. Over the past six months, the relative strength of its shares against the market has been -7.88%. At the current price of S$4.09, shares in Parkway Life Real Estate Investment Trust are trading at 10.62% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Parkway Life Real Estate Investment Trust PE ratio based on its reported earnings over the past 12 months is 19.64. The shares are currently trading at S$4.09.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Parkway Life Real Estate Investment Trust's management team is headed by:
Here are the top five shareholders of Parkway Life Real Estate Investment Trust based on the size of their shareholding:
